The Department of Health (DoH) on Saturday advised against the mixing of Covid-19 vaccines from different platforms until it was proven safe through extensive studies.
Germany and Canada were reported to have approved the use of Vaxzevria from British-Swedish drugmaker AstraZeneca as first dose and the Pfizer-BioNTech tozinameran or the Moderna mRNA-1273 as second dose.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.